Mineki Saito Selected Research

Mineki Saito Research Topics

Disease

19	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2020 - 04/2003
10	Infections 01/2020 - 10/2004
7	Spinal Cord Diseases 12/2017 - 07/2003
7	T-Cell Leukemia (Leukemia, T Cell) 12/2017 - 02/2009
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2019 - 02/2009
2	Multiple Sclerosis 12/2017 - 04/2008
2	Virus Diseases (Viral Diseases) 10/2010 - 07/2003
2	Disease Susceptibility (Diathesis) 12/2007 - 03/2005
1	RNA Virus Infections 01/2021
1	Lymphoma (Lymphomas) 10/2017
1	Human Influenza (Influenza) 01/2017
1	Testicular Neoplasms (Testicular Cancer) 01/2017
1	Allergic Contact Dermatitis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 05/2013
1	Inflammation (Inflammations) 05/2013
1	Neoplasms (Cancer) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2008
1	Inclusion Body Myositis 01/2008
1	Vasculitis (Vasculitides) 02/2006
1	Collagen Diseases (Collagen Disease) 02/2006
1	Communicable Diseases (Infectious Diseases) 05/2005
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2004
1	HTLV-I Infections (HTLV-I Infection) 04/2003
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2002
1	Disease Progression 12/2002
1	Miyoshi myopathy 12/2002

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 06/2014 - 10/2010
3	Messenger RNA (mRNA)IBA 12/2019 - 02/2009
3	LigandsIBA 12/2017 - 07/2003
2	CytokinesIBA 12/2019 - 04/2003
2	Trans-Activators (Trans-Acting Factor)IBA 12/2017 - 05/2013
2	VaccinesIBA 01/2017 - 06/2014
2	AntibodiesIBA 06/2014 - 04/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2007 - 03/2005
2	Interferon-alpha (Interferon Alfa)IBA 07/2006 - 01/2004
1	Attenuated VaccinesIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Viral RNAIBA 11/2019
1	CC ChemokinesIBA 12/2017
1	Minocycline (Cyclops)FDA LinkGeneric 12/2017
1	Chemotactic FactorsIBA 12/2017
1	CalciumIBA 10/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2017
1	Therapeutic UsesIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	AntigensIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	Immunoglobulin G (IgG)IBA 06/2014
1	Pharmaceutical PreparationsIBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	EpitopesIBA 10/2011
1	Biological ProductsIBA 10/2010
1	OX40 LigandIBA 10/2010
1	ChemokinesIBA 10/2010
1	Oncogene Proteins (Oncogene Protein)IBA 08/2010
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2008
1	CX3C Chemokine Receptor 1IBA 03/2008
1	HTLV-I AntibodiesIBA 01/2008
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2007
1	Peptides (Polypeptides)IBA 12/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2006
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2006
1	Aggrecans (Aggrecan)IBA 01/2006
1	Vitamin D FDA LinkGeneric 05/2005
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2005
1	methyl 4-azidophenylacetimidate (APAI)IBA 05/2005
1	HLA-A Antigens (HLA-A)IBA 03/2005
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2004
1	InterleukinsIBA 10/2004
1	Interleukin-10 (Interleukin 10)IBA 10/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2004
1	InterferonsIBA 01/2004
1	Antiviral Agents (Antivirals)IBA 07/2003
1	DysferlinIBA 12/2002

Therapy/Procedure

2	Therapeutics 07/2006 - 01/2004
1	Immunotherapy 01/2013
1	Ligation 10/2011
1	Oral Administration 10/2005